US 8198255
SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1
granted A61KA61K31/7105A61K9/127
Quick answer
US patent 8198255 (SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1) held by The Board of Regents of the University of Oklahoma expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/7105, A61K9/127, A61K9/19